Methods for treating cholestasis
AssigneeMirum Pharmaceuticals, Inc.
InventorsThomas JAECKLIN, Alejandro DORENBAUM
Life of this patent
Estimating the term…
Abstract
Provided herein are methods for treating cholestasis in a subject having a liver disease. The method includes administering to the subject an Apical Sodium-dependent Bile Acid Transporter (ASBTI). More specifically, the present invention relates to methods for treating cholestasis in a subject where the method includes administering an ASBTI to a subject at a dose of at least 10 μg/kg/day.
Claims22
1-102. (canceled)
A method for treating progressive familial intrahepatic cholestasis (PFIC) in a subject in need of such treatment comprising administering to the subject maralixibat in an amount of from about 560 μg/kg/day to about 1400 μg/kg/day.
Dependencies are inferred from the claim text.